ID23307A - Polimorf zopolrestat monohidrat - Google Patents

Polimorf zopolrestat monohidrat

Info

Publication number
ID23307A
ID23307A IDP990796A ID990796A ID23307A ID 23307 A ID23307 A ID 23307A ID P990796 A IDP990796 A ID P990796A ID 990796 A ID990796 A ID 990796A ID 23307 A ID23307 A ID 23307A
Authority
ID
Indonesia
Prior art keywords
polyoror
monohidrat
zopolrestat
zopolrestat monohidrat
polyoror zopolrestat
Prior art date
Application number
IDP990796A
Other languages
English (en)
Inventor
John Francis Lambert
Timothy Norris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID23307A publication Critical patent/ID23307A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP990796A 1998-08-21 1999-08-20 Polimorf zopolrestat monohidrat ID23307A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
ID23307A true ID23307A (id) 2000-04-05

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990796A ID23307A (id) 1998-08-21 1999-08-20 Polimorf zopolrestat monohidrat

Country Status (31)

Country Link
US (1) US6159976A (id)
EP (1) EP0982306A3 (id)
JP (1) JP2000072769A (id)
KR (1) KR20000017411A (id)
CN (1) CN1245804A (id)
AP (1) AP9901662A0 (id)
AU (1) AU4453299A (id)
BG (1) BG103674A (id)
BR (1) BR9903873A (id)
CA (1) CA2280590A1 (id)
EA (1) EA199900675A3 (id)
EE (1) EE9900385A (id)
GT (1) GT199900137A (id)
HR (1) HRP990259A2 (id)
HU (1) HUP9902783A3 (id)
ID (1) ID23307A (id)
IL (1) IL131419A0 (id)
IS (1) IS5155A (id)
MA (1) MA26678A1 (id)
NO (1) NO994027L (id)
NZ (1) NZ337363A (id)
OA (1) OA11150A (id)
PA (1) PA8480601A1 (id)
PE (1) PE20000993A1 (id)
PL (1) PL335016A1 (id)
SG (1) SG83147A1 (id)
TN (1) TNSN99159A1 (id)
TR (1) TR199901996A2 (id)
UY (1) UY25668A1 (id)
YU (1) YU39899A (id)
ZA (1) ZA995297B (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12653825B2 (en) 2010-07-16 2026-06-16 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
HUE031506T2 (en) 2010-07-16 2017-07-28 Univ Columbia Aldose reductase inhibitors and their use
US20140228319A1 (en) * 2013-02-13 2014-08-14 Banavara L. Mylari Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
ES2966094T3 (es) 2016-06-21 2024-04-18 Univ Columbia Compuestos 4-oxo-3,4-dihidrotieno[3,4-d]piridazina como inhibidores de la aldosa reductasa y métodos de uso de los mismos
IL272246B2 (en) 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
CN113840825A (zh) 2019-04-01 2021-12-24 应用治疗公司 醛糖还原酶抑制剂
MX2021013511A (es) 2019-05-07 2022-02-23 Univ Miami Tratamiento y deteccion de neuropatias heredadas y trastornos asociados.
WO2021202523A1 (en) 2020-03-31 2021-10-07 Applied Therapeutics, Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
KR20230005944A (ko) 2020-05-01 2023-01-10 어플라이드 테라퓨틱스 인크. 소르비톨 데히드로게나제 결핍 치료를 위한 알도스 리덕타제 억제제
EP4211136B1 (en) * 2020-09-08 2025-08-20 Assia Chemical Industries Ltd. Solid state forms of at-001 and process for preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia

Also Published As

Publication number Publication date
EA199900675A2 (ru) 2000-02-28
YU39899A (sh) 2002-12-10
PE20000993A1 (es) 2000-10-04
BG103674A (en) 2000-03-31
GT199900137A (es) 2001-02-09
IS5155A (is) 2000-02-22
OA11150A (en) 2003-04-16
EP0982306A3 (en) 2000-07-05
HUP9902783A3 (en) 2001-01-29
NO994027L (no) 2000-02-22
PA8480601A1 (es) 2000-09-29
TR199901996A2 (xx) 2000-03-21
HRP990259A2 (en) 2000-06-30
CN1245804A (zh) 2000-03-01
HUP9902783A2 (hu) 2000-12-28
PL335016A1 (en) 2000-02-28
HU9902783D0 (en) 1999-10-28
AU4453299A (en) 2000-03-09
US6159976A (en) 2000-12-12
EP0982306A2 (en) 2000-03-01
CA2280590A1 (en) 2000-02-21
EE9900385A (et) 2000-04-17
SG83147A1 (en) 2001-09-18
EA199900675A3 (ru) 2000-06-26
BR9903873A (pt) 2000-09-19
NZ337363A (en) 2001-01-26
JP2000072769A (ja) 2000-03-07
ZA995297B (en) 2001-02-19
NO994027D0 (no) 1999-08-20
AP9901662A0 (en) 1999-09-30
TNSN99159A1 (fr) 2005-11-10
KR20000017411A (ko) 2000-03-25
IL131419A0 (en) 2001-01-28
UY25668A1 (es) 2001-08-27
MA26678A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
ID29066A (id) Turunan fenilglisina
ID27423A (id) Turunan kuinolin
DE69919529D1 (de) Lungevenenablationskatheter
ID23234A (id) Turunan-turunan benzosulfona
DE69940286D1 (de) Brenstoffzellenstapel
IS5585A (is) Lyfjaskömmtunarbúnaðir
ID27484A (id) Turunan adenosina
DE69919117D1 (de) Seilklemme
ID27547A (id) Turunan kuinolin
ID24221A (id) Tempat patrum
DE69910986D1 (de) Atmosphärenteilchenanalysator
ID27049A (id) Tienopirimidin-tienopirimidin
DE69904737D1 (de) Streifenkodelesegerät
DE69922449D1 (de) Bandeinfädlungsvorrichtung
DE69922729D1 (de) Achsschubausgleich
DE69932936D1 (de) Atemabsaugkathetervorrichtung
DE69938476D1 (de) Münzschiebespielgerät
FI980739A0 (fi) Timmerknut
EA199900675A3 (ru) Полиморф моногидрата зополрестата
FI980187A0 (fi) Vattenturbinsystem
ID28356A (id) Turunam tiazola
DE69935559D1 (de) Bussignalleitungstreiber
FI980335A0 (fi) Statisk elenergimaetare
DE69907543D1 (de) Röhrchenindexiervorrichtung
DE69905102D1 (de) Spritzgiessmaschinensteuerung